RCM Technologies (NASDAQ: RCMT) jumped 32% to $25.47 on April 7, following FY2025 annual results released April 3 that showed Specialty Health Care revenue up 15% year-over-year to $164.1 million. The market repriced sharply. The search data said it was coming.
What the Search Data Showed Before the Print
Google Search interest for "RCM Healthcare" was up 311% year-over-year as of early April, according to Paradox Intelligence data. That reading sits well above any seasonal pattern and represents a genuine change in state rather than a cyclical bounce. Search interest for "RCM Technologies" itself was up 64% year-over-year and 28% quarter-over-quarter in the same period.
Healthcare staffing is not a business where search demand lags revenue by years. When hospitals and school systems search for specialty staffing providers at unusual rates, it typically reflects active procurement activity. The signal-to-revenue link is direct: RCM's Specialty Health Care segment, which now represents 51.4% of total revenue, places nurses, therapists, allied health professionals, and school-based specialists. Clients who need to fill those roles search for providers.
The FY2025 result confirmed the trend. Specialty Health Care revenue grew from $142.7 million to $164.1 million. Q4 Specialty Health Care revenue was $48.0 million, up from $41.0 million a year earlier. Total Q4 revenue of $86.5 million beat the comparable quarter by 12.4%. The company reported adjusted EBITDA of $30.7 million for the full year, up 18.9% from $25.9 million the prior year.
The Company Link
RCM Technologies operates across three segments: Specialty Health Care (51.4% of FY2025 revenue), Engineering (37.7%), and Life Sciences, Data and Solutions (10.9%). The search signal is linked specifically to Specialty Health Care, which is the dominant driver. Engineering, which serves aerospace and defense, power, and industrial clients, provides secondary exposure to the continued buildout in critical infrastructure.
The stock was trading at $19.30 before the earnings release on April 3. The 32% move to $25.47 brings market cap to approximately $188 million. At roughly 8.8x adjusted EBITDA on current-year numbers, the company trades at a material discount to staffing sector comps, which typically clear 12-15x.
What to Watch
The search signal trend for RCM Healthcare over the next 4-6 weeks will indicate whether the underlying demand that drove FY2025 results is holding into Q1 FY2026. A sustained or rising trend would suggest the earnings acceleration continues. A reversal would call the durability into question. The company's Engineering segment is a secondary monitor: infrastructure project backlogs tied to AI data center and grid work represent a meaningful growth vector that has not yet moved meaningfully in search data.
This is for informational purposes only and does not constitute investment advice.
